ICVV President Attends Iran Pharma 2026

Dr. Hassan Morovati, President of the International Congress of Vaccine and Vaccination (ICVV) and President of the Razi Vaccine and Serum Research Institute, highlighted the importance of strengthening scientific and industrial collaboration and advancing vaccine-related infrastructure during the 11th Iran Pharma International Exhibition.

During his visit, Dr. Morovati described Iran Pharma as an important platform for exploring the capabilities of the pharmaceutical and biotechnology sectors, accessing high-quality raw materials and specialized equipment, and expanding collaboration with knowledge-based companies and domestic manufacturers.

He emphasized that modernizing equipment and strengthening vaccine and biological production infrastructure, alongside closer interaction among scientific institutions, industry, and technology-driven companies, can facilitate knowledge and technology transfer and contribute to a more sustainable supply chain.

This approach aligns with the objectives of the International Congress of Vaccine and Vaccination (ICVV) to strengthen the vaccine ecosystem and foster effective connections among research, technology, and industry.

The Congress, jointly organized by the Razi Vaccine and Serum Research Institute and Pasteur Institute of Iran, will be held on December 16–17, 2026, at Milad Tower, Tehran, Iran.